Connect your AI

NTHI NTHI Net Investment in Lease

Net Investment in Lease at other companies

Nuvation BioNUVB

——

Crinetics PharmaceuticalsCRNX

——

Other financials

Income statement

Revenue$40.0K-7.0%

Operating income-$7.1M+77.9%

Net income-$8.8M+72.7%

EPS (diluted)-$0.38+78.7%

Balance sheet

Cash & equivalents$138.6K-97.5%

Total debt$666.1K—

Total equity-$13.2M-37.5%

Total assets$3.3M-60.6%

Cash flow

Operating cash flow-$7.0M-23.7%

CapEx$125.0K—

Free cash flow-$5.2M—

Valuation

Market cap$114.62M+51.0%

Enterprise value$115.15M+51.1%

P/S1,432.9×—

Profitability

Operating margin-46,870.7%—

Net margin-51,613.3%—

FCF margin-26,083.2%—

Returns & leverage

Return on equity338.1%—

Debt / equity-0.1×—

Current ratio0.1×-0.3×

Where this comes from

Reported directly by NTHI in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: NTHI’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about NTHI's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is NTHI's net investment in lease?: NTHI (NTHI) reported net investment in lease of $340.64K in Q1 2026.